Ascent Therapeutics Inc — Form D/A
Ascent Therapeutics Inc of Cambridge, MA, a company, filed a Form D amendment with the SEC on 2009-05-27. The offering totals $19.0M, of which $19.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-05-27
- Form: D/A
- Accession: 0001417010-09-000004
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $19.0M
- Amount sold: $19.0M
- Investors: 4
- Date of first sale: 2007-10-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-110449
Issuer
- Name: Ascent Therapeutics Inc
- CIK: 0001417010
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2006
- Address: 67 Rogers Street, Cambridge, MA, 02142
- Phone: (617) 715-1999
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Jens Eckstein | Director | Cambridge, MA |
| Frederick Jones | Director | Exton, PA |
| Athan Kuliopulos | Director | Boston, MA |
| LAUREN SILVERMAN | Director | CAMBRIDGE, MA |
| Michael Webb | Director | Wheaton, IL |
| Stephen Hunt | Executive Officer | N/A, U0 |
| Frederick Jones | Executive Officer | Exton, PA |
| Thomas McMurry | Executive Officer | Cambridge, MA |
| Christopher K Mirabelli | Director | Cambridge, MA |
| Robert K Kamen | Director | Cambridge, MA |
| Stephen K Hunt | Executive Officer | Cambridge, MA |
| Thomas K McMurry | Executive Officer | Cambridge, MA |
| Jnes Eckstein | Director | Boston, MA |
| Frederick Jones, III, M.D., MBA | Director | Cambridge, MA |
| Frederick Jones, III, M.D., MBA | Executive Officer | Cambridge, MA |
| Lauren K Silverman | Director | Cambridge, MA |
| Michael K Webb | Director | Cambridge, MA |
Other filings by this issuer (1)
More